Immunology of experimental and natural human hookworm infection

Human hookworm infection is one amongst the most prevalent of the neglected tropical diseases. An informative experimental animal model, that is, one that parallels a human infection, is not available for the study of human hookworm infection. Much of our current understanding of the human immune response during hookworm infection relies on the studies from experimental infection of hookworm‐naïve individuals or the natural infections from individuals residing in hookworm‐endemic areas. The experimental human infections tend to be acute, dose‐controlled infections, often with a low larval inoculum so that they are well tolerated by human volunteers. Natural hookworm infections usually occur in areas where hookworm transmission is constant and infection is chronic. In cases where there has been drug administration in an endemic area, re‐infection often occurs quickly even amongst those who were treated. Hence, although many of the characteristics of experimental and natural hookworm infection differ, both models have elements in common: mainly an intense Th2 response with the production of total and specific IgE as well as elevated levels of eosinophilia, IL‐5, IL‐10 and TNF. While hookworm infection affects millions of individuals worldwide, much of the human immunology of this infection still needs to be studied and understood.

[1]  R. Speare,et al.  Characterising the Mucosal and Systemic Immune Responses to Experimental Human Hookworm Infection , 2012, PLoS pathogens.

[2]  P. Hotez,et al.  A history of hookworm vaccine development , 2011, Human vaccines.

[3]  R. Corrêa-Oliveira,et al.  Induction of CD4+CD25+FOXP3+ Regulatory T Cells during Human Hookworm Infection Modulates Antigen-Mediated Lymphocyte Proliferation , 2011, PLoS neglected tropical diseases.

[4]  R. Speare,et al.  Suppression of Inflammatory Immune Responses in Celiac Disease by Experimental Hookworm Infection , 2011, PloS one.

[5]  S. Brooker,et al.  Necator americanus and Helminth Co-Infections: Further Down-Modulation of Hookworm-Specific Type 1 Immune Responses , 2011, PLoS neglected tropical diseases.

[6]  M. Cappello,et al.  Twenty-First Century Progress Toward the Global Control of Human Hookworm Infection , 2011, Current infectious disease reports.

[7]  Steven Reed,et al.  Vaccines to combat the neglected tropical diseases , 2011, Immunological reviews.

[8]  A. Loukas,et al.  Developing vaccines to combat hookworm infection and intestinal schistosomiasis , 2010, Nature Reviews Microbiology.

[9]  A. Loukas,et al.  The immunology of human hookworm infections , 2010, Parasite immunology.

[10]  D. Pritchard,et al.  Experimental hookworm infection: a randomized placebo-controlled trial in asthma , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  D. Pritchard,et al.  Immunologic profiles of persons recruited for a randomized, placebo-controlled clinical trial of hookworm infection. , 2009, The American journal of tropical medicine and hygiene.

[12]  R. Corrêa-Oliveira,et al.  Early stage-specific immune responses in primary experimental human hookworm infection. , 2008, Microbes and infection.

[13]  A. Loukas,et al.  Binding of Excreted and/or Secreted Products of Adult Hookworms to Human NK Cells in Necator americanus-Infected Individuals from Brazil , 2008, Infection and Immunity.

[14]  A. Loukas,et al.  Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis , 2008, Expert review of vaccines.

[15]  P. Hotez Hookworm and Poverty , 2008, Annals of the New York Academy of Sciences.

[16]  J. Utzinger,et al.  Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. , 2008, JAMA.

[17]  N. Kabatereine,et al.  Malaria and hookworm infections in relation to haemoglobin and serum ferritin levels in pregnancy in Masindi district, western Uganda. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[18]  Peter J. Hotez,et al.  Hookworm vaccines. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  D. Pritchard,et al.  Basophil competence during hookworm (Necator americanus) infection. , 2007, The American journal of tropical medicine and hygiene.

[20]  S. Brooker,et al.  Stage-specific immune responses in human Necator americanus infection , 2007, Parasite immunology.

[21]  D. Pritchard,et al.  Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. , 2006, The American journal of tropical medicine and hygiene.

[22]  Maria Elena Bottazzi,et al.  New technologies for the control of human hookworm infection. , 2006, Trends in parasitology.

[23]  Peter J Hotez,et al.  Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm , 2006, The Lancet.

[24]  R. Speare,et al.  A proof of concept study establishing Necator americanus in Crohn’s patients and reservoir donors , 2005, Gut.

[25]  V. Wright,et al.  Immune responses following experimental human hookworm infection , 2005, Clinical and experimental immunology.

[26]  N. Karunaweera,et al.  Effects of climatic, socio–economic and behavioural factors on the transmission of hookworm (Necator americanus) on two low-country plantations in Sri Lanka , 2005, Annals of tropical medicine and parasitology.

[27]  A. Loukas,et al.  Immunobiology of hookworm infection. , 2005, FEMS immunology and medical microbiology.

[28]  D. Pritchard,et al.  The immunoepidemiology of human hookworm infection , 2004, Parasite immunology.

[29]  A. Loukas,et al.  A Secreted Protein from the Human Hookworm Necator americanus Binds Selectively to NK Cells and Induces IFN-γ Production , 2004, The Journal of Immunology.

[30]  D. Pritchard,et al.  Immune responses in human necatoriasis: association between interleukin-5 responses and resistance to reinfection. , 2004, The Journal of infectious diseases.

[31]  R. Corrêa-Oliveira,et al.  Cellular responses and cytokine production in post‐treatment hookworm patients from an endemic area in Brazil , 2004, Clinical and experimental immunology.

[32]  Peter J Hotez,et al.  Human hookworm infection in the 21st century. , 2004, Advances in parasitology.

[33]  Dirk Engels,et al.  Soil-transmitted helminth infections: updating the global picture. , 2003, Trends in parasitology.

[34]  P. Hotez,et al.  Necator americanus: maintenance through one hundred generations in golden hamsters (Mesocricetus auratus). I. Host sex-associated differences in hookworm burden and fecundity. , 2003, Experimental parasitology.

[35]  P. Hotez,et al.  Emerging patterns of hookworm infection: influence of aging on the intensity of Necator infection in Hainan Province, People's Republic of China. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  M. Nesheim,et al.  Nutritional impact of intestinal helminthiasis during the human life cycle. , 2002, Annual review of nutrition.

[37]  A. Loukas,et al.  Immune Responses in Hookworm Infections , 2001, Clinical Microbiology Reviews.

[38]  A. Polderman,et al.  Parasite-specific antibody and cellular immune responses in humans infected with Necator americanus and Oesophagostomum bifurcum , 2001, Parasitology Research.

[39]  J. Katz,et al.  Hookworms, malaria and vitamin A deficiency contribute to anemia and iron deficiency among pregnant women in the plains of Nepal. , 2000, The Journal of nutrition.

[40]  A. Polderman,et al.  Prenatal immune priming with helminth infections: parasite‐specific cellular reactivity and Th1 and Th2 cytokine responses in neonates , 2000, Allergy.

[41]  R. Stoltzfus,et al.  Malaria, hookworms and recent fever are related to anemia and iron status indicators in 0- to 5-y old Zanzibari children and these relationships change with age. , 2000, The Journal of nutrition.

[42]  R. Stoltzfus,et al.  Hookworm control as a strategy to prevent iron deficiency. , 2009, Nutrition reviews.

[43]  P. Hotez,et al.  Hookworm: developmental biology of the infectious process. , 1996, Current opinion in genetics & development.

[44]  D. Bundy,et al.  IgG4 responses to antigens of adult Necator americanus: potential for use in large-scale epidemiological studies. , 1996, Bulletin of the World Health Organization.

[45]  D. Pritchard,et al.  Immunoepidemiology of human necatoriasis: correlations between antibody responses and parasite burdens , 1995, Parasite immunology.

[46]  R. Quinnell,et al.  Immunity in humans to Necator americanus‐. IgE, parasite weight and fecundity , 1995, Parasite immunology.

[47]  D. Pritchard,et al.  Isotypic variation in antibody responses in a community in Papua New Guinea to larval and adult antigens during infection, and following reinfection, with the hookworm Necator americanus , 1992, Parasite immunology.

[48]  J. Behnke,et al.  Necator americanus in the DSN hamster: density-dependent expulsion of adult worms during primary infection , 1990, Parasitology.

[49]  J. Behnke,et al.  Acquired resistance to the human hookworm Necator americanus in mice , 1988, Parasite immunology.

[50]  T. Nutman,et al.  The clinical and immunologic responses of normal human volunteers to low dose hookworm (Necator americanus) infection. , 1987, The American journal of tropical medicine and hygiene.

[51]  D. Pritchard,et al.  Antigen expression during development of the human hookworm, Necator americanus (Nematoda) , 1987, Parasite immunology.

[52]  G. R. Rajasekariah,et al.  Site of resistance to Necator americanus in hamsters. , 1985, Acta tropica.

[53]  R. A. Yeates,et al.  Antibody responses in self-infections with Necator americanus. , 1978, Transactions of the Royal Society of Tropical Medicine and Hygiene.